HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: L'Oreal S.A.

This article was originally published in The Rose Sheet

Executive Summary

L'Oreal S.A.: Net sales increased 11.2% to $2.84 bil. (FFr 16.5 bil.) for the first quarter, based on an April 14 exchange rate of $1 = 5.8155 FFr. Excluding the impact of structural changes and exchange rates, sales rose 6.3%. The company completed its purchase of Maybelline on Feb. 12, 1996 for $44 a share ("The Rose Sheet" Feb. 12, 1996, In Brief). Other acquisitions affecting revenue results include the purchase of the Swiss lab Giuliani S.A., on Oct. 1 and the German lab Henning Berlin GmbH on Nov. 1. Exchange rates positively affected sales 3.3%, the company added...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004047

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel